Creating Biomedical Technologies to Improve Health

NEWS & EVENTS

Newsroom

NIBIB in the News • December 10, 2012
The mHealth summit last week in Washington, D.C. provided conference attendees with the opportunity to evaluate the state of the field, discuss regulatory issues, and ponder the future of mobile health technologies. Read the full article from The Atlantic.
NIBIB in the News • December 9, 2012
At the recent mHealth summit in Washington, D.C., Dr. Pettigrew described the handheld Diagnostic Magnetic Resonance (DMR) device developed by NIBIB-funded researchers at Massachusetts General Hospital. Read the full article from Vanguard.
Grantee News • November 24, 2012

The New York Times features NIBIB grantees Bob Langer and Ralph Weissleder as being “on the front lines of turning discoveries made in the lab into a range of drugs and drug deliver systems. Without this kind of technology transfer, the thinking goes, scientific discoveries might well sit on the shelf, stifling innovation.” Read the full article from The New York Times.

Grantee News • November 20, 2012

NIBIB-funded research has resulted in a new spectrum of voltage-sensitive dyes (VSDs) that improves optical imaging of brain and heart electrical activity. Fluorinated hemicyanine dyes provide spectral compatibility with newly available optical technologies, offering better photostability and improving the signal to noise ratio (S:N) of the optically recorded voltage activity in cells, tissues, and organs. Read the full article from Proceedings of the National Academy of Sciences.

Science Highlights • November 19, 2012
A picture speaks a thousand words, and when the picture is an x-ray, ultrasound, MRI scan, or other medical image, it is an essential chapter in a person’s health history. Every day, doctors, nurses, and other health care professionals rely on such images and other medical multimedia in diagnosing or monitoring illnesses and planning a patient’s care.
NIBIB in the News • November 19, 2012
NIBIB-funded researchers at Northwestern develop new approach to treat autoimmune disease. Comments by William Heetderks, Ph. D., NIBIB Associate Director of Extramural Programs are included. Read more about breakthroughs regarding the immune system and Multiple Sclerosis.
Press Releases • November 19, 2012
In a mouse model of multiple sclerosis (MS), researchers funded by the National Institutes of Health have developed innovative technology to selectively inhibit the part of the immune system responsible for attacking myelin–the insulating material that encases nerve fibers and facilitates electrical communication between brain cells.
Grantee News • November 19, 2012

In a mouse model of multiple sclerosis (MS), NIBIB-funded researchers Stephen Miller and Lonnie Shea at Northwestern University have developed innovative biotechnology to selectively inhibit the part of the immune system responsible for attacking myelin–the insulating material that encases nerve fibers and facilitates electrical communication between brain cells. Read the full article from Northwestern University.

Science Highlights • November 13, 2012

Identifying new compounds to treat heart disease, cancer, or other inflammatory and immune-related disorders may get easier using a precisely tailored application of solid state nuclear magnetic resonance (NMR) spectroscopy–which can reveal a protein’s entire 3-D structure within its natural surroundings.

Grantee News • November 8, 2012
NIBIB grantees Dr. Gordana Vunjak-Novakovic and Dr. Norbert Pelc have been inducted into the National Academy of Engineering (NAE). Founded in 1964, the NAE marshals the expertise and insights of eminent engineers to advise the nation on matters involving engineering and technology.

Pages